Efficacy and Safety of Superior Trunk Block Versus Interscalene Block for Post-operative Analgesia in Shoulder Surgeries
1 other identifier
interventional
40
1 country
1
Brief Summary
Efficacy and safety of superior trunk block versus interscalene block for post-operative analgesia in shoulder surgeries
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 30, 2023
CompletedFirst Posted
Study publicly available on registry
August 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedJune 28, 2024
May 1, 2023
6 months
July 30, 2023
June 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
diaphragmatic paralysis postoperative
o The incidence of diaphragmatic paralysis postoperative assessed by Diaphragmatic excursion distance by Ultrasound
within 24 hours after surgery
Secondary Outcomes (3)
analgesic efficacy
within 24 hours after surgery
rescue analgesia
within 24 hours after surgery
Post operative nausea and vomiting
within 24 hours after surgery
Study Arms (2)
interscalene block group
ACTIVE COMPARATORparticipants undergoing shoulder surgeries will receive ultrasound guided interscalene block
superior trunk block group
ACTIVE COMPARATORparticipants undergoing shoulder surgeries will receive ultrasound guided superior trunk block
Interventions
will receive a 20 ml mixture of local anesthetic solution prepared as 10 ml of bupivacaine 0.5% diluted with 10 ml normal saline 0.9% will be injected in interscalene block.
will receive a 20 ml mixture of local anesthetic solution prepared as 10 ml of bupivacaine 0.5% diluted with 10 ml normal saline 0.9% will be injected in superior trunk block.
Eligibility Criteria
You may qualify if:
- Patients American Society of Anaesthesiologists physical status (ASA) is I to II.
- Both genders.
- Aged group from 21 to 50 years old.
- Patients electively scheduled for shoulder surgery under general anesthesia with normal coagulation profile.
You may not qualify if:
- Refusal of the procedure or participation in the study.
- Any history or evidence of coagulopathy.
- Evidence of infection at injection site.
- Allergy to study drugs.
- Patients with pulmonary severe respiratory disease.
- Herniated cervical disc or cervical myelopathy.
- Pre-existing neuropathy of the operative limb
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ainshams University
Cairo, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2023
First Posted
August 7, 2023
Study Start
May 1, 2023
Primary Completion
November 1, 2023
Study Completion
December 1, 2023
Last Updated
June 28, 2024
Record last verified: 2023-05